$65M at stake in fraud trial for ‘Pharma Bro’ Martin Shkreli
reuters
The defence lawyer for Martin Shkreli says the former pharmaceutical CEO would lose a $65-million US stake in a drug company he founded if he’s convicted at his securities fraud trial.
